Related Experiment Video
Updated: Jan 8, 2026

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
Role of HOXA transcript antisense RNA myeloid-specific 1 in cancer (Review)
Yipei Jing1, Xiaoqi Li1, Ye Guo1
1Department of Clinical Laboratory, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100730, P.R. China.
Abstract:
A newly recognized class of master regulators known as long non-coding RNAs (lncRNAs) has emerged as key modulators of cancer. Among them, HOXA transcript antisense RNA myeloid-specific 1 (HOTAIRM1) was initially identified in acute promyelocytic leukemia, where it resides within the HOXA gene cluster. The involvement of HOTAIRM1 has been indicated in the pathogenesis of multiple cancer types, including glioma, acute myeloid leukemia and osteosarcoma, has been well documented. HOTAIRM1 controls the growth, invasion and migration of tumors through different mechanisms and it is associated with the clinicopathological characteristics of patients with tumors. The present review describes the expression, function and molecular mechanism of HOTAIRM1 in different types of cancer and discusses the future obstacles in diagnosing and treating malignant tumors.
More Related Videos
Related Concept Videos
lncRNA - Long Non-coding RNAs
Hedgehog Signaling Pathway
Abnormal Proliferation
MicroRNAs
MicroRNAs
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

